|
시장보고서
Emerging Therapies for Diabetes
|
Abstract
Research Overview
This Frost & Sullivan research service titled Emerging Therapies in Diabetes
provides in-depth information about the various commercial products and
therapies for diabetes and related health complications, available in the
market today and those on the verge of commercialization.
Table of Contents
1 EXECUTIVE SUMMARY
- Scope and Methodology
- Scope and Segmentation
- Methodology
- Diabetes--An Overview
- Types and Related Health Complications
- Underlying Causes; Symptomatic Diagnosis and Treatment Approach
- Key Findings
2 EMERGING THERAPIES IN DIABETES - TECHNOLOGY ANALYSIS
- Technology Primer
- Current Diabetes Therapies
- Noteworthy Emerging Diabetes Therapies
- Noteworthy Developments
- Corporate Sector
- Research Institutions and Universities
- Future Trends; Strategic Recommendations
- Future Trends
- Analyst Views and Strategic Recommendations
3 TECHNOLOGY ADOPTION FACTOR ANALYSIS
- Technology Drivers and Restraints
- Pharmacotherapy
- Insulin Therapy
- Pancreas Transplant
- Islet Cell Transplant
- Artificial Pancreas
- Gene Therapy
- Funding Analysis; Alliances; Mergers and Acquisitions
- Funding
- Alliances; Mergers; and Acquisitions
4 ASSESSMENT OF EMERGING THERAPIES AND SCREENING METHODS FOR DIABETES IN KEY COMPANIES AND UNIVERSITIES
- Technology Innovations in Companies--North America
- Breakthrough Inhalable Insulin Therapy Relieves People of Painful
Injections--USA
- New Class of Oral Drugs for Diabetes--USA
- Unique Diabetic Drug Based on Drug Repositioning Strategy for Type 2
Diabetes--Canada
- Antidiabetic Drugs Promote Natural Metabolism by Mimicking Natural
Hormones--USA
- Oral Insulin Spray for the Treatment of Diabetes--Canada
- Fast Acting Nasal Spray Formulation of Insulin for Diabetes Patients--USA
- Novel Protein-Based Therapeutics for Treating Diabetes-Related
Complications--USA
- Noninvasive Screening Technology for Detecting Prediabetes and
Diabetes--USA
- Screening for Diabetes through Diagnostic Imaging of the Retina--USA
- Novel Drug for the Treatment of Type 1 Diabetes with Potential Long-Term
Benefits--USA
- Unique Combination Drug for Patients with Type 2 Diabetes and
Hypertension--Canada
- Novel Combination Drug For Type 2 Diabetes--USA
- Novel Small Molecule Drug Controls Blood Sugar without Causing
Hypoglycemia--USA
- Development of Bioartificial Pancreas for the Treatment of Type 1
Diabetes--USA
- Integrated and Compact Insulin Delivery System--USA
- Technology Innovations in Companies--Europe
- Novel Drug Addresses the Twin Problem of Diabetes and Obesity--France
- Nanotechnology-Based Insulin Pump for Pain-Free Delivery of
Insulin--Switzerland
- Novel Range of Diabetes Care Products to Serve a Broader Patient
Community--Denmark
- Novel Antidiabetic Drug Targeting the Pancreatic Islet
Dysfunction--Switzerland
- Novel Drug Preserves Beta Cell Function in Type 1 Diabetes--Sweden
- Novel Drugs that Treat Diabetes and its Complications Enter Clinical
Trials--UK
- Technology Innovations in Companies--APAC
- Healthy Neonatal Porcine Islet Cell Transplantation Technology for
Insulin Production--Australia
- Novel Peptide-Based Drug that Uniquely Targets Diabetes and its
Resultant Complications--Australia
- Topical Human Insulin Product for both Type 1 and Type 2
Diabetes--Australia
- Combo Drugs Gaining Recognition for Treating Type 2 Diabetes--Japan
- Technology Innovations in Universities--World
- Identification of Potential Therapeutic Targets for Treatment of
Metabolic Syndrome--USA
- New Method of Treating Diabetes Using a Naturally Occurring Fatty
Acid--USA
- Novel Designer Approach to Treat Type 1 Diabetes--USA
- Use of Chromium as an Adjunct in the Pharmaceutical Therapy of
Diabetes--USA
- Study Identifies the Role of Brain in Diabetes Therapy--USA
- Delivering Insulin Genes through a Unique Mechanism Boosts Gene Therapy
of Diabetes--USA
5 PATENTS AND KEY CONTACTS
- Patents
- US Patents
- European Patents
- Key Contacts
- Corporate Contacts
- University Contacts
6 DECISION SUPPORT DATABASE
- Biotechnology--Companies; R&D; Funding--World
- Number of Biotech Companies (2002-2012)
- Government R&D Investment in Biotechnology (2002-2012)
- Venture Capital Investment in Biotechnology (2002-2012)
- Population; Healthcare and Pharmaceutical R&D Expenditures--World
- Total Population
- Total Healthcare Expenditure
- Pharmaceutical R&D Expenditure
- Pervalence of Diabetes and Related Health Risks--World
- Diabetes Incidence (2002-2012)
- Prevalence of Diabetes (2002-2012)
- Diabetes Foot Ulcer Prevalence (2002-2012)
- Obesity Prevalence (2002-2012)
- Cataract Blindness (2002-2012)
- Cardiovascular Prevalence (2002-2012)
- Organ Transplants--World
- Number of Kidney Transplants (2002-2006)
- Number of Pancreas Transplants (2002-2006)
|
